Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?

Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?

<h4>Background</h4> <p>Menopausal hormone therapy (MHT) increases breast cancer risk; however, most cohort studies omit MHT use after enrolment and many infer menopausal age.</p> <h4>Methods</h4> <p>We used information from serial questionnaires from the UK...

Descripció completa

Dades bibliogràfiques
Autors principals:	Jones, M, Schoemaker, M, Wright, L, McFadden, E, Griffin, J, Thomas, D, Hemming, J, Wright, K, Ashworth, A, Swerdlow, A
Format:	Journal article
Idioma:	English
Publicat:	Nature Publishing Group 2016

Ítems similars

Psychological stress, adverse life events and breast cancer incidence: a cohort investigation in 106,000 women in the United Kingdom.
per: Schoemaker, M, et al.
Publicat: (2016)

Body mass index, exercise, and other lifestyle factors in relation to age at natural menopause: analyses from the breakthrough generations study.
per: Morris, D, et al.
Publicat: (2012)

Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study.
per: Bodicoat, D, et al.
Publicat: (2014)

Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study
per: Johns, L, et al.
Publicat: (2018)

Reply to 'Comment on 'Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study"
per: Johns, L, et al.
Publicat: (2018)

The relationship between obesity and exposure to light at night: cross-sectional analyses of over 100,000 women in the Breakthrough Generations Study.
per: McFadden, E, et al.
Publicat: (2014)

Correction to: Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study
per: Danielle H. Bodicoat, et al.
Publicat: (2020-02-01)

Smoking and risk of breast cancer in the Generations Study cohort
per: Michael E. Jones, et al.
Publicat: (2017-11-01)

Maternal breast cancer risk in relation to birthweight and gestation of her offspring
per: Anthony J. Swerdlow, et al.
Publicat: (2018-10-01)

Progestogen in menopausal hormone therapy and breast cancer risk
per: Jin-Sung Yuk
Publicat: (2024-05-01)

Menopausal hormone therapy and risk factors of breast cancer development
per: A E Protasova, et al.
Publicat: (2017-06-01)

Menopausal hormone therapy for women with schizophrenia: what’s stopping us?
per: Reilly, TJ, et al.
Publicat: (2024)

A validated model of serum anti-müllerian hormone from conception to menopause.
per: Thomas W Kelsey, et al.
Publicat: (2011-01-01)

Hand osteoarthritis, menopause and menopausal hormone therapy
per: Watt, F
Publicat: (2015)

Oral contraceptives and menopausal hormone therapy as breast cancer risk categories
per: I. V. Vуsotskaya, et al.
Publicat: (2019-09-01)

Menopausal hormone therapy and 20-year breast cancer mortality
per: Beral, V, et al.
Publicat: (2019)

Menopause hormone therapy in the changing trends of breast cancer in India
per: Meeta Meeta, et al.
Publicat: (2020-01-01)

Menopausal metabolic syndrome and the risks of menopausal hormone therapy: the solutions
per: A.E. Esedova, et al.
Publicat: (2020-12-01)

Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
per: Beral, V, et al.
Publicat: (2011)

Cardiometabolic disorders and menopausal hormone therapy
per: V Ye Balan, et al.
Publicat: (2017-10-01)

Menopauseal hormonal therapy and the risk of breast cancer in the light of new data
per: O.О. Yefimenko
Publicat: (2022-08-01)

Menopausal hormone therapy and breast cancer risk: All progestogens are not the same
per: Irene Lambrinoudaki
Publicat: (2021-01-01)

Individual choice of menopausal hormone therapy
per: T V Ovsyannikova, et al.
Publicat: (2016-08-01)

THE EFFECTS OF HORMONAL THERAPY IN MENOPAUSE
per: Eduard Crauciuc, et al.
Publicat: (2018-06-01)

Progestogens in menopausal hormone therapy
per: Małgorzata Bińkowska, et al.
Publicat: (2015-06-01)

Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
per: Xiaoliang Wang, et al.
Publicat: (2022-04-01)

The choice of hormonal and alternative therapy in menopausal and post-menopausal period
per: Kuznetsova I.V.
Publicat: (2018-02-01)

Correction of menopausal disorders: new possibilities of menopausal hormone therapy
per: L. Yu. Karakhalis
Publicat: (2022-04-01)

Algorithms for prescribing menopausal hormone therapy in different periods of menopause
per: T.F. Tatarchuk, et al.
Publicat: (2022-08-01)

Menopause and menopausal hormone therapy in women: cardiovascular benefits and risks
per: Anna Svatikova, et al.
Publicat: (2018-01-01)

What is China’s True Unemployment Rate?
per: Giles, J, et al.
Publicat: (2005)

Hormonal modulation of breast cancer gene expression: implications for intrinsic subtyping in pre-menopausal women
per: Sarah M Bernhardt, et al.
Publicat: (2016-11-01)

Menopausal hormonal therapy or non-hormonal treatment: rational choice
per: T Yu Pestrikova, et al.
Publicat: (2015-06-01)

What is true? What is false?
per: Sigrún Stefánsdóttir
Publicat: (2015-03-01)

Osteoporosis/Osteopenia in Post-Menopausal Breast Cancer Patients Receiving Hormonal Therapy
per: Rahimullah Khattak, et al.
Publicat: (2022-09-01)

Hormone replacement therapy in menopause as a risk factor for developing breast cancer
per: Natasha Firmino Souto, et al.
Publicat: (2014-07-01)

Hormone replacement therapy in menopause as a risk factor for developing breast cancer
per: Natasha Firmino Souto, et al.
Publicat: (2014-07-01)

Hormone replacement therapy in menopause as a risk factor for developing breast cancer
per: Natasha Firmino Souto, et al.
Publicat: (2014-07-01)

Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy
per: Giulia Gava, et al.
Publicat: (2019-10-01)

Defining bioidentical hormones for menopause-related symptoms
per: Whelan AM, et al.
Publicat: (2011-03-01)